CHICAGO For a number of reasons we have all heard a lot about generic drugs lately. The high cost of new drugs the rise in number of people without medical insurance in the U.S. and perhaps even the U.S. governments efforts to accelerate the entry of generics into the market to help cap some of the rising costs of health care are just a few reasons. In fact it is estimated